Phyllodes Breast Tumors: A Guide to Diagnosis, Grading and Treatment

Receiving a diagnosis of a phyllodes tumor can be overwhelming, particularly because these growths are rare and behave differently than more common types of breast cancer. This overview is designed to help you understand your diagnosis and prepare for meaningful discussions with your oncology team.

Overview of phyllodes tumors

Phyllodes tumors are rare "fibroepithelial" neoplasms, meaning they develop in both the connective tissue (stroma) and the epithelial lining of the breast. They account for less than 1% of all breast tumors and are distinct from common carcinomas because they originate outside the breast's ducts and lobules.

These tumors are categorized into three grades based on how their cells look under a microscope:

• Benign: The most common type; these are non-cancerous and slow-growing but can recur if not fully removed.
• Borderline: These have features of both benign and malignant tumors, posing a higher risk of returning after surgery.
• Malignant: These are cancerous, can grow rapidly and have the potential to spread to other parts of the body, most commonly the lungs.

Diagnosis

Diagnosing a phyllodes tumor is often challenging because they closely resemble fibroadenomas, which are common, harmless breast lumps, on standard imaging.

• Imaging: Doctors typically use mammography, ultrasound or MRI. On an ultrasound, these tumors often appear as solid, well-defined masses, sometimes containing fluid-filled cysts.
• Biopsy: A core needle biopsy is the standard first step. However, because these tumors are large and varied, a needle sample may not always capture the full picture.
• Pathology: In many cases, the final diagnosis is only confirmed after the entire mass is surgically removed and examined by a pathologist.

Treatment options

The primary treatment for all phyllodes tumors, regardless of grade, is surgery. Because these tumors have a high tendency to return in the same area, surgeons aim for "clear margins."

• Wide Local Excision (Lumpectomy): The surgeon removes the tumor along with at least 1 centimeter of healthy surrounding tissue to reduce the risk of recurrence.
• Mastectomy: If the tumor is very large relative to the size of the breast, or if it is a recurrent malignant tumor, a total mastectomy (removal of the entire breast) may be necessary.
• Radiation Therapy: While rare for benign cases, radiation may be recommended after surgery for borderline or malignant tumors to help prevent the tumor from coming back.
• Chemotherapy: This is generally not effective for phyllodes tumors because they do not behave like typical breast cancers. It is typically reserved only for rare, aggressive cases that have spread to other organs.

Side effects and recovery

Recovery depends largely on the extent of the surgery performed.

• Surgical Side Effects: Common short-term effects include pain, bruising and swelling at the incision site. Some patients may develop a seroma (a buildup of fluid under the skin) that requires draining.
• Cosmetic Changes: Because a 1-centimeter margin of healthy tissue is required, the shape or size of the breast may change. You may wish to discuss reconstructive options with your surgeon.
• Psychological Impact: Living with a rare diagnosis can cause anxiety. Surveillance is frequent, especially in the first two years, which can be a source of "scanxiety" for many patients.

Conclusion

While the word "tumor" is frightening, most phyllodes growths are benign and successfully treated with surgery alone. For those with borderline or malignant types, a multidisciplinary team — including surgeons and sometimes radiation oncologists — is key to long-term health.

Your most important tool is an open dialogue with your doctor. Consider asking: "What was the grade of my tumor?" and "What is the plan for long-term monitoring to ensure it doesn't return?"

Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.